HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Terbium-149

Also Known As:

149Tb radioisotope; Tb-149 radioisotope

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9

Experts

1.	Beyer, G-J: 1 article (04/2004)
2.	Buchegger, F: 1 article (04/2004)
3.	Comor, J J: 1 article (04/2004)
4.	Hartley, O: 1 article (04/2004)
5.	Künzi, G: 1 article (04/2004)
6.	Miederer, M: 1 article (04/2004)
7.	Senekowitsch-Schmidtke, R: 1 article (04/2004)
8.	Soloviev, D: 1 article (04/2004)
9.	Vranjes-Durić, S: 1 article (04/2004)
10.	Apostolidis, Christos: 1 article (05/2003)

Related Diseases

1.

Neoplasms (Cancer)

01/01/1996 - "Alpha- and beta-emitting radiolanthanides in targeted cancer therapy: the potential role of terbium-149."
04/01/2004 - "This study demonstrates high-efficiency sterilisation of single cancer cells in a SCID mouse model of leukaemia using rituximab, a monoclonal antibody that targets CD20, labelled with terbium-149, an alpha-emitting radionuclide. "
05/01/2003 - "Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion protein."

Related Drugs and Biologics

1.	Radioisotopes (Radionuclides)
2.	Monoclonal Antibodies
3.	Rituximab (Mabthera)
4.	Immunoconjugates (Immunoconjugate)
5.	Cadherins (E-Cadherin)
6.	Proteins (Proteins, Gene)
7.	Bismuth-213

Related Therapies and Procedures

1.	Therapeutics